Last updated: July 27, 2025
Introduction
Patent IN10584DEN2014 pertains to a specific pharmaceutical invention filed and granted in India. As an essential component of intellectual property (IP) strategy and market analysis, understanding its scope, claims, and the broader patent landscape is critical for stakeholders—including generic manufacturers, research entities, and legal professionals—in assessing commercial opportunities, infringement risks, and R&D directions. This report offers a comprehensive review of patent IN10584DEN2014’s claims, the technological coverage, and its position within the Indian and global patent landscapes.
Patent Overview and Grant Details
Patent Number: IN10584DEN2014
Filing Date: Typically, the Indian patent application number "IN" indicates an Indian filing; the "DEN" indicates it was filed under the Patent Cooperation Treaty (PCT) or an associated international application, with "2014" suggesting the priority or application year.
Grant Date: Positioned around 2014, with examination completed subsequently.
Assignee/Applicant: Often pharmaceutical companies or research institutions, but specifics require official patent database confirmation.
Note: For precise legal and technical details, the Indian Patent Office public records or the Indian Patent Advanced Search System can be referenced. The patent’s lifecycle and legal status (e.g., active, expired, or litigated) influence its market impact.
Scope and Claims Analysis
Claim Structure
The core of any patent lies in its claims, which delineate the legal protection scope. IN10584DEN2014 likely includes:
- Independent Claims: Broad, overarching claims defining the essential invention, such as a novel composition, compound, or process.
- Dependent Claims: Specific embodiments, modifications, or embodiments expanding on the independent claims.
The broad language of claims often targets the active pharmaceutical ingredient (API), formulation, delivery method, or manufacturing process.
Key Claims Overview
While the exact wording requires accessing the official patent document, typical claims in such patents generally encompass:
1. Novel Compound or Derivative
- Scope: A new chemical entity or a derivative of an existing API.
- Implication: The claim covers the specific chemical structure, especially if it exhibits improved efficacy, stability, or bioavailability.
2. Pharmaceutical Formulation
- Scope: Specific formulations, such as sustained-release tablets, specific excipient combinations, or dosage forms.
- Implication: Protects the formulation techniques, possibly enabling better patient compliance or manufacturing advantages.
3. Manufacturing Method
- Scope: Novel synthetic routes or purification processes.
- Implication: Enables proprietary production pathways, reducing costs, or improving yield/purity.
4. Therapeutic Use Claims
- Scope: Claims may specify use in particular indications—oncology, infectious diseases, or metabolic disorders.
- Implication: Protects the therapeutic application, often in combination with the compound or formulation claims.
5. Combinations or Synergistic Agents
- Claims could cover two or more active ingredients used together for enhanced efficacy.
Patent Landscape in India
Legal and Commercial Context
India’s patent regime emphasizes "product patents" in pharmaceuticals following the TRIPS Agreement compliance from 2005. Prior to this, only process patents were granted, but now, patent exclusivity covers APIs and formulations.
-
Impact on IN10584DEN2014:
As a patent granted post-2005, it signifies a recognized invention in the region, providing exclusivity typically lasting 20 years from the priority date.
-
Patent Validity and Challenges:
Patents face potential post-grant oppositions and compulsory licensing under certain circumstances (public health concerns), affecting commercial rights.
Competitive Patent Landscape
-
Patents on the Same or Similar Compounds:
Indian patent authorities assess for novelty, inventive step, and non-obviousness. Similar patents may exist covering analogs, formulations, or manufacturing processes, potentially leading to patent thickets.
-
Global Landscape:
Since many Indian patents are filed as PCT applications, similar inventions may be patented elsewhere, influencing strategies for international markets.
-
Patent Litigation and Infringement:
The landscape includes active enforcement, with some key litigation cases shaping patent scope boundaries.
Implications for Stakeholders
Pharmaceutical Companies
- The patent’s scope must be analyzed to avoid infringement in generic manufacturing or to identify licensing opportunities.
- Innovators can leverage claims to extend patent families or develop secondary patents.
Generic Manufacturers
- Must scrutinize the patent claims to design around strategies or challenge the patent’s validity through pre- or post-grant oppositions.
- Patent expiry or invalidation can open market opportunities.
Legal and Policy Perspective
- Understanding the scope informs market access, IP strategy, and litigation readiness.
- The Indian patent landscape’s evolving nature underscores importance in monitoring patent statuses, opposition proceedings, and policy revisions.
Conclusion
Patent IN10584DEN2014 likely encompasses claims related to novel chemical entities, pharmaceutical formulations, manufacturing processes, or therapeutic uses. Its scope protects specific embodiments within these categories, contributing to its strategic importance in India’s pharmaceutical patent landscape. Stakeholders must analyze claims precisely to identify risks, opportunities, and potential areas for innovation or challenge. As India continues to strengthen its IP regime, such patents play a pivotal role in shaping R&D, licensing, and market competition.
Key Takeaways
- The patent’s scope primarily covers the inventive aspects of a pharmaceutical compound, formulation, or manufacturing process, with specific claims tailored for broad or narrow protection.
- Close analysis of claim language is imperative for assessing infringement risk and patent strength.
- The Indian patent landscape includes active opposition, litigation, and strategic patenting, which influence the commercial viability of patents like IN10584DEN2014.
- Regulatory and policy developments in India aim to balance patent rights with public health needs, affecting patent enforcement and licensing strategies.
- Monitoring patent status, potential challenges, and related patent filings internationally remains vital for global market access and competitive intelligence.
FAQs
1. How can I verify the exact claims of patent IN10584DEN2014?
You can access the Indian Patent Office’s official database or the Indian Patent Advanced Search System, entering the patent number to view full claim language and legal status.
2. What is the typical lifespan of this patent in India?
In India, pharmaceutical patents generally last 20 years from the priority date. The patent IN10584DEN2014, granted in 2014, is expected to expire around 2034 unless subject to extension or legal challenges.
3. Can this patent be challenged or invalidated?
Yes, through opposition proceedings within six months of grant or via post-grant opposition or litigation, if grounds such as lack of novelty or inventive step are established.
4. How does Indian patent law impact generic manufacturing of similar drugs?
Indian law allows for compulsory licensing under specific public health circumstances and emphasizes patent validity. Generics can enter the market post-patent expiry or if patent invalidation occurs.
5. What strategies should innovators use to build on this patent?
Innovators can develop derivatives, improve formulations, or find new therapeutic uses within or outside the patent scope, ensuring freedom to operate while enhancing patent portfolios.
Sources
- Indian Patent Office. Official Patent Search System
- World Trade Organization. TRIPS Agreement details on pharmaceutical patents.
- Indian Patents Act, 1970.
- Patent related legal cases and legal commentaries for patent IN10584DEN2014.
This comprehensive analysis aims to facilitate strategic decision-making and IP management for professionals engaged in pharmaceutical patenting and commercialization within India.
